Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cytokine ; 96: 94-101, 2017 08.
Artículo en Inglés | MEDLINE | ID: mdl-28390267

RESUMEN

In an effort to improve the regenerative nature of corneal repair, this study reports the use of an in vitro human corneal fibroblasts (HCFs) wound model after treatment with three of the main growth factors (GFs) involved in corneal healing: transforming growth factor beta 1 (TGFß1), platelet-derived growth factor BB-isoform (PDGF-BB), and basic fibroblast growth factor (bFGF) in order to delve in cell proliferation and differentiation processes. HCFs were mechanically wounded. The individual effect of TGFß1, PDGF-BB, and bFGF on cell proliferation and differentiation during the repair process was studied at different time points until wound closure. Wound dimensions and morphological changes were evaluated by microscopy. Cell proliferation and myofibroblast differentiation were analyzed by immunofluorescence cytochemistry. Changes in cell morphology were apparent at Day 4. PDGF-BB- and bFGF-treated cells had fibroblast-like morphology. TGFß1 stimulated proliferation in the wound edge and surrounding area, induced myofibroblast differentiation and inhibited cellular migration. PDGF-BB induced rapid wound closure due to proliferation, high motility, and late myofibroblast differentiation. The time course of closure induced by bFGF was similar to that for PDGF-BB, but was mostly due to proliferation in the wound area, and inhibited myofibroblast differentiation. Each of the GFs induced increases in responses promoting stromal repair differently. This study provides insight regarding how to optimize the outcome of stromal repair following corneal injury.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Córnea/citología , Factor 2 de Crecimiento de Fibroblastos/farmacología , Miofibroblastos/efectos de los fármacos , Factor de Crecimiento Derivado de Plaquetas/farmacología , Factor de Crecimiento Transformador beta1/farmacología , Recuento de Células , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Córnea/efectos de los fármacos , Sustancia Propia/citología , Sustancia Propia/efectos de los fármacos , Humanos , Miofibroblastos/fisiología , Cicatrización de Heridas/efectos de los fármacos
2.
J Tissue Eng Regen Med ; 12(2): e737-e746, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-27860426

RESUMEN

The development of treatments that modulate corneal wound healing to avoid fibrosis during tissue repair is important for the restoration of corneal transparency after an injury. To date, few studies have studied the influence of growth factors (GFs) on human corneal fibroblast (HCF) expression of extracellular matrix (ECM) proteins such as collagen types I and III, proteoglycans such as perlecan, or proteins implicated in cellular migration such as α5ß1-integrin and syndecan-4. Using in vitro HCFs, a mechanical wound model was developed to study the influence of the GFs basic fibroblast GF (bFGF), platelet-derived GF (PDGF-BB) and transforming GF-ß1 (TGFß1) on ECM protein production and cellular migration. Our results show that mechanical wounding provokes the autocrine release of bFGF and TGFß1 at different time points during the wound closure. The HCF response to PDGF-BB was a rapid closure due to fast cellular migration associated with a high focal adhesion replacement and a high expression of collagen and proteoglycans, producing nonfibrotic healing. bFGF stimulated nonfibrotic ECM production and limited the migration process. Finally, TGFß1 induced expression of the fibrotic markers collagen type III and α5ß1 integrin, and it inhibited cellular migration due to the formation of focal adhesions with a low turnover rate. The novel in vitro HCF mechanical wound model can be used to understand the role played by GFs in human corneal repair. The model can also be used to test the effects of different treatments aimed at improving the healing process. Copyright © 2016 John Wiley & Sons, Ltd.


Asunto(s)
Becaplermina/farmacología , Movimiento Celular/efectos de los fármacos , Córnea/citología , Matriz Extracelular/metabolismo , Factor 2 de Crecimiento de Fibroblastos/farmacología , Fibroblastos/citología , Factor de Crecimiento Transformador beta1/farmacología , Colágeno Tipo I/metabolismo , Colágeno Tipo III/metabolismo , Medios de Cultivo , Matriz Extracelular/efectos de los fármacos , Fibroblastos/efectos de los fármacos , Proteoglicanos de Heparán Sulfato/genética , Proteoglicanos de Heparán Sulfato/metabolismo , Humanos , Integrinas/genética , Integrinas/metabolismo , Subunidades de Proteína/genética , Subunidades de Proteína/metabolismo , Proteoglicanos/genética , Proteoglicanos/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Células del Estroma/efectos de los fármacos , Células del Estroma/patología , Sindecano-4/genética , Sindecano-4/metabolismo , Cicatrización de Heridas/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA